Generalized Anxiety Disorder - Pipeline Insight, 2021
SKU ID :DEL-19044458 | Published Date: 01-Sep-2021 | No. of pages: 60Description
TOC
Introduction
Executive Summary
Generalized Anxiety Disorder: Overview
• Causes
• Mechanism of Action
• Signs and Symptoms
• Diagnosis
• Disease Management
Pipeline Therapeutics
• Comparative Analysis
Therapeutic Assessment
• Assessment by Product Type
• Assessment by Stage and Product Type
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Late Stage Products (Phase III)
• Comparative Analysis
Cannabidiol: Tilray
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
• Comparative Analysis
Cariprazine: Allergan
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Preclinical stage products
• Comparative Analysis
PSY-05: PSY Therapeutics
• Product Description
• Research and Development
• Product Development Activities
Drug profiles in the detailed report…..
Inactive Products
• Comparative Analysis
Generalized Anxiety Disorder Key Companies
Generalized Anxiety Disorder Key Products
Generalized Anxiety Disorder- Unmet Needs
Generalized Anxiety Disorder- Market Drivers and Barriers
Generalized Anxiety Disorder- Future Perspectives and Conclusion
Generalized Anxiety Disorder Analyst Views
Generalized Anxiety Disorder Key Companies
Appendix
Tables & Figures
Table 1 Total Products for Generalized Anxiety Disorder
Table 2 Late Stage Products
Table 3 Mid Stage Products
Table 4 Early Stage Products
Table 5 Pre-clinical & Discovery Stage Products
Table 6 Assessment by Product Type
Table 7 Assessment by Stage and Product Type
Table 8 Assessment by Route of Administration
Table 9 Assessment by Stage and Route of Administration
Table 10 Assessment by Molecule Type
Table 11 Assessment by Stage and Molecule Type
Table 12 Inactive Products
Companies
• ChemRar Research and Development Institute, LLC
• Tilray
• PSY Therapeutics
• VistaGen Therapeutics
• SAGE Therapeutics
• Bionomics
• Pear Therapeutics
• Lundbeck
• OWP Pharmaceuticals
• Fabre-Kramer Pharmaceuticals
- PRICE
-
$1500$4500